HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1- (2- amino- 3- methyl- butyryl)- azetidine- 2- carbonitrile

structure in first source

Also Known As:

AMAC cpd

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Azetines
    - Azetidines: 8
      - 1-(2-amino-3-methyl-butyryl)-azetidine-2-carbonitrile: 1
Organic Chemicals: 140
- Nitriles: 233
  - 1-(2-amino-3-methyl-butyryl)-azetidine-2-carbonitrile: 1

Experts

1.	Belyakov, Sergei: 1 article (06/2005)
2.	Ferraris, Dana: 1 article (06/2005)
3.	Lautar, Susan L: 1 article (06/2005)
4.	Li, William: 1 article (06/2005)
5.	Rojas, Camilo: 1 article (06/2005)
6.	Slusher, Barbara S: 1 article (06/2005)
7.	Thomas, Ajit G: 1 article (06/2005)
8.	Waldon, Daniel: 1 article (06/2005)
9.	Wozniak, Krystyna M: 1 article (06/2005)
10.	Wu, Ying: 1 article (06/2005)

Related Diseases

1.	Psychotic Disorders (Schizoaffective Disorder) 06/28/2005 - "We have developed a potent DPP IV inhibitor (IC50 = 30 nM), 1-(2-amino-3-methyl-butyryl)-azetidine-2-carbonitrile (AMAC), which has shown efficacy in two established models of psychosis: mescaline-induced scratching and amphetamine-induced hyperactivity. "

Related Drugs and Biologics

1.	Dipeptidyl-Peptidase IV Inhibitors
2.	Mescaline (Peyote)
3.	Amphetamine (Amfetamine)